- Home
- PHH vs FENC Comparison
PHH vs FENC Comparison
Compare PHH & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHH
- FENC
- Stock Information
- Founded
- PHH 2016
- FENC 1996
- Country
- PHH China
- FENC United States
- Employees
- PHH N/A
- FENC N/A
- Industry
- PHH Package Goods/Cosmetics
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PHH Consumer Discretionary
- FENC Health Care
- Exchange
- PHH Nasdaq
- FENC Nasdaq
- Market Cap
- PHH 160.1M
- FENC 156.9M
- IPO Year
- PHH 2024
- FENC 2001
- Fundamental
- Price
- PHH $13.22
- FENC $6.09
- Analyst Decision
- PHH
- FENC Strong Buy
- Analyst Count
- PHH 0
- FENC 2
- Target Price
- PHH N/A
- FENC $14.00
- AVG Volume (30 Days)
- PHH 482.9K
- FENC 120.6K
- Earning Date
- PHH 01-01-0001
- FENC 03-10-2025
- Dividend Yield
- PHH N/A
- FENC N/A
- EPS Growth
- PHH N/A
- FENC N/A
- EPS
- PHH 0.02
- FENC N/A
- Revenue
- PHH $2,381,851.00
- FENC $47,538,000.00
- Revenue This Year
- PHH N/A
- FENC $28.99
- Revenue Next Year
- PHH N/A
- FENC $63.21
- P/E Ratio
- PHH $654.18
- FENC N/A
- Revenue Growth
- PHH N/A
- FENC 123.69
- 52 Week Low
- PHH $3.70
- FENC $3.96
- 52 Week High
- PHH $14.75
- FENC $11.29
- Technical
- Relative Strength Index (RSI)
- PHH N/A
- FENC 39.43
- Support Level
- PHH N/A
- FENC $6.25
- Resistance Level
- PHH N/A
- FENC $6.90
- Average True Range (ATR)
- PHH 0.00
- FENC 0.34
- MACD
- PHH 0.00
- FENC -0.04
- Stochastic Oscillator
- PHH 0.00
- FENC 19.82
Stock Price Comparison Chart: PHH vs FENC
About PHH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries specialize in providing skincare and cosmetic products under its brand name Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.